CARM Carisma Therapeutics Inc.

Fundamentals / CIK 0001485003 / USD

Carisma Therapeutics Inc. reported $52.60M in revenue and net income of $8.04M for the trailing twelve months ended September 30, 2025 (up 1232.4% year over year), with a 20.6% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CARM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2024), reported in USD.

$37.51M$18.76M$0-$102.8MFY 2015 Revenue: $490KFY 2015 Net Income: -$33.45M2015FY 2016 Revenue: $406KFY 2016 Net Income: $1.89M2016FY 2017 Revenue: $0FY 2017 Net Income: -$29.03M2017FY 2018 Revenue: $0FY 2018 Net Income: -$33.69M2018FY 2019 Revenue: $0FY 2019 Net Income: -$107.5M2019FY 2020 Revenue: $11.24MFY 2020 Net Income: -$22.40M2020FY 2021 Revenue: $26.54MFY 2021 Net Income: -$336K2021FY 2022 Revenue: $9.80MFY 2022 Net Income: -$61.23M2022FY 2023 Revenue: $14.90MFY 2023 Net Income: -$86.88M2023FY 2024 Revenue: $19.60MFY 2024 Net Income: -$60.48M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $19.60M $14.90M $9.80M $26.54M $11.24M $0 $0 $0 $406K $490K
Research & Development $59.67M $74.12M $56.62M $25.31M $29.19M $24.66M $14.08M $12.51M $13.48M $26.34M
Total Operating Expenses $81.81M $103.7M $66.00M $35.09M $32.31M $108.5M $34.50M $29.68M $27.11M $36.19M
Operating Income -$62.18M -$88.73M -$56.16M -$8.55M -$21.08M -$108.5M -$34.50M -$29.25M $2.87M -$35.20M
EBITDA -$58.83M -$85.89M -$54.27M -$8.46M -$20.95M -$108.3M -$34.29M -$28.97M $3.04M -$34.83M
Interest Income -- -- $1.85M $17K $224K -- -- -- -- --
Interest Expense -- -- -- -- -- -- -- -- -- $0
Income Before Tax -- -- -$23.76M -$8.61M -$20.95M -$107.5M -$33.69M -$29.03M $1.90M -$33.45M
Income Tax Expense -- -- -$3.88M -$8.27M $1.45M $0 $0 $0 $5.0K $0
Net Income -$60.48M -$86.88M -$61.23M -$336K -$22.40M -$107.5M -$33.69M -$29.03M $1.89M -$33.45M
Basic EPS -$1.46 -$2.59 -$28.77 $0.00 -$0.19 -$1.18 -$0.55 -$1.11 $0.09 -$1.76
Diluted EPS -$1.46 -$2.59 -$28.77 $0.00 -$0.19 -$1.18 -$0.55 -$1.11 $0.09 -$1.76
Basic Shares Outstanding 41.5M 33.5M 2.1M 182.3M 118.2M 90.9M 61.8M 26.1M 21.1M 19.0M
Diluted Shares Outstanding 41.5M 33.5M 2.1M 182.3M 118.2M 90.9M 61.8M 26.1M 21.7M 19.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue $45.30M $0 $3.70M $3.60M $3.40M $9.20M $3.40M $4.30M
Research & Development $197K $2.42M $9.16M $15.58M $11.33M $15.31M $17.46M $19.41M
Total Operating Expenses $1.44M $5.78M $13.06M $21.51M $16.53M $20.87M $22.91M $26.74M
Operating Income $43.81M -$5.78M -$9.33M -$17.86M -$13.14M -$11.67M -$19.51M -$22.45M
EBITDA $43.81M -$5.78M -$8.67M -$17.19M -$12.41M -$11.41M -$17.82M -$21.73M
Income Tax Expense $0 $0 $0 -- $0 $0 $0 --
Net Income $44.72M -$9.77M -$9.27M -$17.64M -$12.70M -$11.16M -$18.98M -$20.96M
Basic EPS $1.07 -$0.23 -$0.22 -- -$0.31 -$0.27 -$0.46 --
Diluted EPS $1.07 -$0.23 -$0.22 -- -$0.31 -$0.27 -$0.46 --
Basic Shares Outstanding 41.8M 41.8M 41.8M -- 41.6M 41.5M 40.9M --
Diluted Shares Outstanding 41.9M 41.8M 41.8M -- 41.6M 41.5M 40.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $17.91M $77.61M $24.19M $162.6M $52.39M $48.12M $50.42M $14.68M $25.34M $36.08M
Short-Term Investments -- $0 $27.80M $0 -- -- -- -- -- --
Cash & Short-Term Investments $17.90M $77.60M $166.9M $162.6M $52.39M $48.12M $50.42M $14.68M $25.34M $36.08M
Accounts Receivable, Net -- -- $0 $21.01M $0 -- -- -- -- --
Total Current Assets $23.82M $80.47M $54.59M $205.6M $62.87M $54.45M $51.76M $14.98M $25.93M $36.31M
Property, Plant & Equipment, Net $4.38M $6.76M $8.63M $43K $123K $238K $321K $522K $796K $407K
Goodwill -- -- $0 $13.06M $13.06M $13.06M $13.06M $13.06M $16.86M $0
Intangible Assets -- -- $0 $14.70M $46.40M $46.40M $46.40M $46.40M $60.50M $0
Long-Term Investments -- -- -- $0 -- -- -- -- -- --
Other Non-Current Assets -- -- $0 $123K $349K $196K $0 $120K $0 $13K
Total Non-Current Assets $6.63M $9.08M $30K $35.14M $59.96M $59.92M $59.80M $60.12M $78.17M $514K
Total Assets $30.46M $89.55M $72.15M $240.7M $122.8M $114.4M $111.6M $75.10M $104.1M $36.83M
Accounts Payable $2.08M $3.93M $1.73M $2.85M $3.10M $1.90M $1.37M $907K $1.67M $1.25M
Deferred Revenue (Current) $3.73M $1.41M $2.46M $0 $1.50M $0 -- $0 $425K $406K
Other Current Liabilities $1.06M $965K $523K $460K $489K $446K $0 -- -- $0
Total Current Liabilities $16.05M $15.91M $19.67M $11.57M $18.05M $8.52M $6.11M $4.72M $3.98M $7.58M
Deferred Revenue (Non-Current) $41.25M $45.00M $0 $1.50M $1.50M $0 -- -- -- --
Other Non-Current Liabilities $318K $926K $1.04M $0 $118K $0 $313K $215K $0 $423K
Total Non-Current Liabilities $42.31M $47.11M $0 $57.47M $114.0M $132.5M $61.24M $52.34M $61.44M $10.30M
Total Liabilities $58.37M $63.02M $107.0M $69.04M $132.1M $141.1M $67.35M $57.06M $65.42M $17.88M
Total Debt (incl. Leases) $2.48M $3.12M $6.45M $124K $271K $112K -- -- -- --
Common Stock $41K $40K $2.0K $199K $140K $107K $77K $35K $25K $20K
Retained Earnings -$305.6M -$245.1M -$158.2M -$316.3M -$315.9M -$293.5M -$186.0M -$152.3M -$123.3M -$125.2M
Accumulated Other Comp. Income -- $0 -$41K $0 -- -- -- -- -- --
Total Stockholders' Equity -- $26.53M -$157.1M $171.7M -$9.23M -$26.70M $44.21M $18.03M $38.68M $18.94M
Total Equity -$27.91M $26.53M -$142.7M -$81.78M -$9.23M -$26.70M $44.21M $18.03M $38.68M $18.94M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Cash & Cash Equivalents $2.78M $2.00M $7.74M $17.91M $26.88M $40.36M $56.52M $77.61M
Short-Term Investments -- -- -- -- -- -- -- $0
Cash & Short-Term Investments $2.80M $2.00M $7.70M $17.90M $26.90M $40.40M $56.50M $77.60M
Total Current Assets $5.87M $4.29M $13.95M $23.82M $34.14M $50.72M $60.95M $80.47M
Property, Plant & Equipment, Net $0 $0 $0 $4.38M $5.39M $6.53M $7.55M $6.76M
Total Non-Current Assets $684K $717K $2.00M $6.63M $7.92M $8.62M $12.84M $9.08M
Total Assets $6.55M $5.01M $15.95M $30.46M $42.06M $59.34M $73.80M $89.55M
Accounts Payable $5.57M $4.76M $3.25M $2.08M $1.73M $2.03M $2.17M $3.93M
Deferred Revenue (Current) $0 $0 $0 $3.73M $682K $659K $1.19M $1.41M
Other Current Liabilities $0 $613K $853K $1.06M $1.15M $1.22M $1.19M $965K
Total Current Liabilities $6.81M $8.95M $10.45M $16.05M $10.56M $15.62M $13.14M $15.91M
Deferred Revenue (Non-Current) $0 $41.25M $41.25M $41.25M $41.25M $41.25M $45.00M $45.00M
Other Non-Current Liabilities $0 $169K $231K $318K $519K $815K $1.13M $926K
Total Non-Current Liabilities $609K $42.07M $42.17M $42.31M $42.63M $43.36M $49.76M $47.11M
Total Liabilities $7.42M $51.02M $52.62M $58.37M $53.18M $58.98M $62.90M $63.02M
Total Debt (incl. Leases) $762K $1.70M $2.33M $2.48M $3.32M $3.76M $7.49M $3.12M
Common Stock $41K $41K $41K $41K $41K $41K $41K $40K
Retained Earnings -$279.9M -$324.6M -$314.8M -$305.6M -$287.9M -$275.2M -$264.1M -$245.1M
Accumulated Other Comp. Income -- -- -- -- -- -- -- $0
Total Stockholders' Equity -- -- -- -- -- -- -- $26.53M
Total Equity -$867K -$46.01M -$36.66M -$27.91M -$11.13M $360K $10.89M $26.53M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$60.48M -$86.88M -$61.23M -$336K -$22.40M -$107.5M -$33.69M -$29.03M $1.89M -$33.45M
Depreciation & Amortization $3.35M $2.84M $1.89M $85K $122K $219K $208K $285K $178K $366K
Stock-Based Compensation $3.65M $2.32M $275K $5.14M $1.76M $1.24M $1.28M $1.38M $4.01M $2.53M
Change in Receivables -- -- $21.01M -$24.49M $0 $0 -- -- -- --
Change in Payables -$1.85M $2.19M -$473K -$249K $1.20M $535K $460K -$760K -$742K -$1.21M
Operating Cash Flow -$59.92M -$81.18M -$5.12M -$68.88M -$30.84M -$37.52M -$22.83M -$17.77M $2.54M -$34.53M
Capital Expenditure -$123K -$1.13M -$4.66M -$4.0K -$8.0K -$136K -$2.0K -$10K -- -$287K
Free Cash Flow -$60.04M -$82.31M -$9.78M -$68.88M -$30.84M -$37.66M -$22.83M -$17.77M -- -$34.82M
Purchases of Investments $0 -$34.46M -$129.0M $0 $0 -- -- -- -- --
Investing Cash Flow -$123K $72.41M -$32.56M -$4.0K -$8.0K -$136K -$2.0K $98K $461K -$287K
Common Stock Issued $2.39M $597K $0 $175.0M $37.96M $1.94M $0 $0 $0 $12.65M
Financing Cash Flow $344K $62.18M $33.32M $176.1M $38.11M $35.36M $58.58M $7.00M -$13.82M $16.84M
Net Change in Cash -$59.70M $53.41M -$29.07M $107.2M $7.27M -$2.30M $35.75M -$10.66M -$10.74M -$17.98M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Net Income $44.72M -$9.77M -$9.27M -$17.64M -$12.70M -$11.16M -$18.98M -$20.96M
Depreciation & Amortization $0 $0 $661K $669K $737K $255K $1.69M $722K
Stock-Based Compensation $421K $431K $508K $852K $1.11M $625K $1.06M $873K
Change in Payables $1.14M $781K $1.17M $376K -$328K -$74K -$1.83M $1.82M
Operating Cash Flow $1.91M -$5.90M -$10.07M -$8.35M -$13.02M -$16.12M -$22.43M -$16.10M
Capital Expenditure $0 $0 $0 $0 $0 -$106K -$17K -$561K
Free Cash Flow $1.91M -$5.90M -$10.07M -$8.35M -$13.02M -$16.23M -$22.44M -$16.66M
Purchases of Investments -- -- -- $0 $0 $0 $0 $0
Investing Cash Flow $0 $163K $524K $0 $0 -$106K -$17K $10.44M
Common Stock Issued $0 $0 $0 -$23K $129K $0 $2.29M $597K
Financing Cash Flow -$1.13M $0 -$626K -$620K -$461K $73K $1.35M $101K
Net Change in Cash $778K -$5.74M -$10.17M -$8.97M -$13.48M -$16.15M -$21.09M -$5.56M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -317.2% -595.5% -573.1% -32.2% -187.6% -- -- -- 705.9% -7182.9%
Net Profit Margin -308.6% -583.1% -624.8% -1.3% -199.3% -- -- -- 465.8% -6826.9%
Return on Equity (ROE) -- -327.4% -- -0.2% -- -- -76.2% -161.0% 4.9% -176.6%
Return on Assets (ROA) -198.6% -97.0% -84.9% -0.1% -18.2% -94.0% -30.2% -38.7% 1.8% -90.8%
Current Ratio 1.48x 5.06x 2.78x 17.77x 3.48x 6.39x 8.47x 3.17x 6.51x 4.79x
Quick Ratio 1.11x 4.88x 8.49x 15.88x 2.90x 5.65x 8.25x 3.11x 6.37x 4.76x
Debt to Equity -- 0.12x -- 0.00x -- -- -- -- -- --
Revenue Growth (YoY) +31.5% +52.0% -63.1% +136.2% -- -- -- -100.0% -17.1% -78.2%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -1120.8% -- --
Net Income Growth (YoY) -- -- -- -- -- -- -- -1635.1% -- --
EPS Growth (YoY) -- -- -- -- -- -- -- -1333.3% -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -800.0% -- --
5Y Revenue / Share Growth -- -- -- +656.0% +268.4% -100.0% -100.0% -- -- --
10Y Revenue / Share Growth +208.7% -55.0% -- -- -- -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -102.1% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Operating Margin 20.6% -430.9% -261.3% -317.2% -328.9% -367.0% -564.7% -595.5%
Net Profit Margin 15.3% -461.5% -255.1% -308.6% -314.3% -350.2% -537.8% -583.1%
Return on Equity (ROE) -- -- -- -- -- -- -- -327.4%
Return on Assets (ROA) 122.7% -985.2% -318.2% -198.6% -151.7% -122.2% -110.1% -97.0%
Current Ratio 0.86x 0.48x 1.34x 1.48x 3.23x 3.25x 4.64x 5.06x
Quick Ratio 0.41x 0.22x 0.74x 1.11x 2.55x 2.59x 4.30x 4.88x
Debt to Equity -- -- -- -- -- -- -- 0.12x
Revenue Growth (YoY) +1232.4% -100.0% +8.8% -16.3% -10.5% +155.6% +6.2% +16.3%
Source: SEC EDGAR CompanyFacts (CIK 0001485003) · from December 31, 2012 Data through September 30, 2025 · synced Nov 21, 2026, 05:16 UTC · Open in terminal